$SRNE
Sorrento Therapeutics Inc

2021 Q3 Form 10-Q Financial Statement

#000095017021003247 Filed on November 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3
Revenue $12.06M $11.75M
YoY Change 2.63% 103.41%
Cost Of Revenue $3.387M $2.700M
YoY Change 25.44% -48.08%
Gross Profit $8.675M $9.100M
YoY Change -4.67% 1416.67%
Gross Profit Margin 71.92% 77.43%
Selling, General & Admin $48.49M $24.30M
YoY Change 99.54% -3.7%
% of Gross Profit 558.95% 267.03%
Research & Development $49.45M $32.00M
YoY Change 54.51% 15.91%
% of Gross Profit 570.01% 351.68%
Depreciation & Amortization $3.547M $3.140M
YoY Change 12.96% 141.54%
% of Gross Profit 40.89% 34.51%
Operating Expenses $49.45M $32.00M
YoY Change 54.51% -39.44%
Operating Profit -$101.4M -$83.10M
YoY Change 22.0% 55.97%
Interest Expense $2.900M $2.562M
YoY Change 13.19% -72.91%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$119.8M -$86.40M
YoY Change 38.63% 16.75%
Income Tax $400.0K $100.0K
% Of Pretax Income
Net Earnings -$119.8M -$84.02M
YoY Change 42.58% 30.44%
Net Earnings / Revenue -993.23% -714.91%
Basic Earnings Per Share -$0.40 -$0.33
Diluted Earnings Per Share -$0.40 -$0.33
COMMON SHARES
Basic Shares Outstanding 299.3M 251.2M
Diluted Shares Outstanding 299.3M 257.7M

Balance Sheet

Concept 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $162.7M $75.20M
YoY Change 116.32% 116.71%
Cash & Equivalents $39.74M $75.18M
Short-Term Investments $122.9M
Other Short-Term Assets $3.974M $13.90M
YoY Change -71.41% -16.77%
Inventory $5.427M $2.100M
Prepaid Expenses $12.20M
Receivables $16.45M $14.80M
Other Receivables $0.00 $0.00
Total Short-Term Assets $200.7M $106.0M
YoY Change 89.36% 56.88%
LONG-TERM ASSETS
Property, Plant & Equipment $45.75M $74.30M
YoY Change -38.43% 144.91%
Goodwill $52.90M $38.30M
YoY Change 38.12% 0.0%
Intangibles $321.0M $79.97M
YoY Change 301.38%
Long-Term Investments $51.12M $256.4M
YoY Change -80.06% 915.93%
Other Assets $4.664M $2.125M
YoY Change 119.48% -58.94%
Total Long-Term Assets $552.1M $496.1M
YoY Change 11.29% 0.56%
TOTAL ASSETS
Total Short-Term Assets $200.7M $106.0M
Total Long-Term Assets $552.1M $496.1M
Total Assets $752.8M $602.1M
YoY Change 25.03% 7.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.84M $22.85M
YoY Change 21.84% -14.58%
Accrued Expenses $23.58M $24.56M
YoY Change -4.02% 32.93%
Deferred Revenue $2.284M $4.170M
YoY Change -45.23% 15.42%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $27.49M $18.53M
YoY Change 48.34% -28.4%
Total Short-Term Liabilities $175.2M $92.13M
YoY Change 90.16% -18.27%
LONG-TERM LIABILITIES
Long-Term Debt $83.50M $149.5M
YoY Change -44.14% -36.23%
Other Long-Term Liabilities $1.761M $549.0K
YoY Change 220.77% -99.72%
Total Long-Term Liabilities $85.26M $150.0M
YoY Change -43.17% -36.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $175.2M $92.13M
Total Long-Term Liabilities $85.26M $150.0M
Total Liabilities $621.5M $456.8M
YoY Change 36.05% -17.58%
SHAREHOLDERS EQUITY
Retained Earnings -$1.242B -$886.8M
YoY Change 40.08% 48.54%
Common Stock $1.422B $1.141B
YoY Change 24.6% 64.8%
Preferred Stock
YoY Change
Treasury Stock (at cost) $49.46M $49.46M
YoY Change 0.0% 0.0%
Treasury Stock Shares $7.568M $7.568M
Shareholders Equity $131.5M $205.4M
YoY Change
Total Liabilities & Shareholders Equity $752.8M $602.1M
YoY Change 25.03% 7.35%

Cashflow Statement

Concept 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$119.8M -$84.02M
YoY Change 42.58% 30.44%
Depreciation, Depletion And Amortization $3.547M $3.140M
YoY Change 12.96% 141.54%
Cash From Operating Activities -$83.11M -$42.59M
YoY Change 95.14% -7.07%
INVESTING ACTIVITIES
Capital Expenditures -$1.175M -$2.870M
YoY Change -59.06% 37.32%
Acquisitions
YoY Change
Other Investing Activities $6.571M -$22.36M
YoY Change -129.39% 1827.59%
Cash From Investing Activities $5.396M -$25.23M
YoY Change -121.39% 676.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 40.06M 117.9M
YoY Change -66.01% 422.2%
NET CHANGE
Cash From Operating Activities -83.11M -42.59M
Cash From Investing Activities 5.396M -25.23M
Cash From Financing Activities 40.06M 117.9M
Net Change In Cash -37.66M 50.04M
YoY Change -175.25% -288.76%
FREE CASH FLOW
Cash From Operating Activities -$83.11M -$42.59M
Capital Expenditures -$1.175M -$2.870M
Free Cash Flow -$81.94M -$39.72M
YoY Change 106.29% -9.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0000850261
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36150
dei Entity Registrant Name
EntityRegistrantName
SORRENTO THERAPEUTICS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0344842
dei Entity Address Address Line1
EntityAddressAddressLine1
4955 Directors Place
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
306335789
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39735000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56464000
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
122934000
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
203-4100
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
dei Trading Symbol
TradingSymbol
SRNE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16454000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15506000
CY2021Q3 us-gaap Inventory Net
InventoryNet
5427000
CY2020Q4 us-gaap Inventory Net
InventoryNet
1831000
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12196000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8712000
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
3974000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3721000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
200720000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
86234000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45750000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31861000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
76674000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
42052000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
320970000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
73675000
CY2021Q3 us-gaap Goodwill
Goodwill
52892000
CY2020Q4 us-gaap Goodwill
Goodwill
43554000
CY2021Q3 srne Equity Securities Fv Ni Noncurrent
EquitySecuritiesFvNiNoncurrent
51120000
CY2020Q4 srne Equity Securities Fv Ni Noncurrent
EquitySecuritiesFvNiNoncurrent
256397000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4664000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2049000
CY2021Q3 us-gaap Assets
Assets
752790000
CY2020Q4 us-gaap Assets
Assets
535822000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
27839000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
24706000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16674000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
20859000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23575000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19198000
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2284000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4485000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11644000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3626000
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
65682000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
398000
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
27486000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
23208000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
175184000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
96480000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
83495000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
92258000
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5083000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6918000
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
119206000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
113185000
CY2021Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
35300000
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
35400000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
79930000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50301000
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
121504000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
549000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1761000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2021Q3 us-gaap Liabilities
Liabilities
621463000
CY2020Q4 us-gaap Liabilities
Liabilities
395091000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
303466554
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
303466554
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
275285582
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
275285582
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
31000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
28000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1421966000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1172346000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1155000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
520000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1242187000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-958279000
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
7568182
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7568182
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
49464000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
49464000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
131501000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
165151000
CY2021Q3 us-gaap Minority Interest
MinorityInterest
-174000
CY2020Q4 us-gaap Minority Interest
MinorityInterest
-24420000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
131327000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
140731000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
752790000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
535822000
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12062000
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11753000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39828000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
28481000
CY2021Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
49448000
CY2020Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
32003000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
147787000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
77307000
CY2021Q3 srne Research And Development In Process And Impairment Of Intangible Assets Finite Lived
ResearchAndDevelopmentInProcessAndImpairmentOfIntangibleAssetsFiniteLived
11125000
CY2020Q3 srne Research And Development In Process And Impairment Of Intangible Assets Finite Lived
ResearchAndDevelopmentInProcessAndImpairmentOfIntangibleAssetsFiniteLived
34884000
srne Research And Development In Process And Impairment Of Intangible Assets Finite Lived
ResearchAndDevelopmentInProcessAndImpairmentOfIntangibleAssetsFiniteLived
23608000
srne Research And Development In Process And Impairment Of Intangible Assets Finite Lived
ResearchAndDevelopmentInProcessAndImpairmentOfIntangibleAssetsFiniteLived
39765000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
48489000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24265000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
142276000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
75027000
CY2021Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1000000
CY2020Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1034000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
3105000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
3018000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
113449000
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
94857000
us-gaap Costs And Expenses
CostsAndExpenses
326670000
us-gaap Costs And Expenses
CostsAndExpenses
202476000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-101387000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-83104000
us-gaap Operating Income Loss
OperatingIncomeLoss
-286842000
us-gaap Operating Income Loss
OperatingIncomeLoss
-173995000
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1800000
CY2020Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1000000
CY2021Q3 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
97000
CY2020Q3 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
238000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
100000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
5900000
CY2021Q3 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-13483000
CY2020Q3 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
0
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
17047000
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
0
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6695000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-51939000
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-300000
CY2020Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
30000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-841000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
7000
CY2021Q3 us-gaap Interest Expense
InterestExpense
2900000
CY2020Q3 us-gaap Interest Expense
InterestExpense
2562000
us-gaap Interest Expense
InterestExpense
7282000
us-gaap Interest Expense
InterestExpense
17664000
us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
53000
us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
179000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-119773000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-86398000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-284460000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-237512000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
386000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
145000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-461000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2050000
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
164000
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-566000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-277000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5821000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-119995000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-87109000
us-gaap Profit Loss
ProfitLoss
-284276000
us-gaap Profit Loss
ProfitLoss
-241283000
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-192000
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3086000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-368000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14324000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-119803000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-84023000
us-gaap Net Income Loss
NetIncomeLoss
-283908000
us-gaap Net Income Loss
NetIncomeLoss
-226959000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.98
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.05
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.05
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
299276000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
251211000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
290029000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217050000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
299276000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
257670000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
290029000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
223509000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-119995000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-87109000
us-gaap Profit Loss
ProfitLoss
-284276000
us-gaap Profit Loss
ProfitLoss
-241283000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
22000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
669000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
635000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
714000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
22000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
669000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
635000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
714000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-119973000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-86440000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-283641000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-240569000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-192000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-3086000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-368000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-14324000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-119781000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-83354000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-283273000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-226245000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
140731000
CY2021Q1 srne Stock Issued During Period Value Upon Issuance Of Warrants
StockIssuedDuringPeriodValueUponIssuanceOfWarrants
9050000
CY2021Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
7500000
CY2021Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
23660000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-75000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
2418000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
230887000
CY2021Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
5378000
CY2021Q2 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
20984000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
688000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-166699000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
185535000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
131327000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
32756000
CY2020Q1 srne Stock Issued During Period Value Upon Issuance Of Warrants
StockIssuedDuringPeriodValueUponIssuanceOfWarrants
13535000
CY2020Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
3682000
CY2020Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
6975000
CY2020Q3 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
6295000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
669000
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
41918000
CY2021Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
812000
CY2021Q3 srne Other Changes To Noncontrolling Interests
OtherChangesToNoncontrollingInterests
651000
CY2021Q3 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
21103000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
22000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-119995000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
55000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-69180000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
51226000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3797000
CY2020Q2 srne Stock Issued During Period Value Upon Issuance Of Warrants
StockIssuedDuringPeriodValueUponIssuanceOfWarrants
25327000
CY2020Q2 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
3335000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-84993000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
80215000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1177000
CY2020Q3 srne Stock Issued During Period Value Upon Issuance Of Warrants
StockIssuedDuringPeriodValueUponIssuanceOfWarrants
53876000
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
63765000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-87109000
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
145284000
us-gaap Profit Loss
ProfitLoss
-284276000
us-gaap Profit Loss
ProfitLoss
-241283000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9603000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8790000
srne Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
3057000
srne Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
2802000
us-gaap Paid In Kind Interest
PaidInKindInterest
5899000
us-gaap Paid In Kind Interest
PaidInKindInterest
10440000
srne Payment Notes Attributed To Accreted Interest Related To Debt Discount
PaymentNotesAttributedToAccretedInterestRelatedToDebtDiscount
11791000
srne Payment Notes Attributed To Accreted Interest Related To Debt Discount
PaymentNotesAttributedToAccretedInterestRelatedToDebtDiscount
0
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
23608000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
39765000
us-gaap Share Based Compensation
ShareBasedCompensation
67509000
us-gaap Share Based Compensation
ShareBasedCompensation
13312000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6695000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-51939000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
100000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
5900000
us-gaap Gain Loss On Investments
GainLossOnInvestments
17047000
us-gaap Gain Loss On Investments
GainLossOnInvestments
0
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-277000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5821000
us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
100000
us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
0
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1834000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1989000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1162000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1524000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
697000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
313000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-4941000
srne Other Acquisitions License Agreements And Investments Paid In Equity
OtherAcquisitionsLicenseAgreementsAndInvestmentsPaidInEquity
9544000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2016000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6058000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4588000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3549000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8556000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
35589000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1544000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
417000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-385000
srne Increase Decrease Right Of Use Assets Operating Leases
IncreaseDecreaseRightOfUseAssetsOperatingLeases
32509000
srne Increase Decrease Right Of Use Assets Operating Leases
IncreaseDecreaseRightOfUseAssetsOperatingLeases
0
srne Deferred Rent And Other Period Increase Decrease
DeferredRentAndOtherPeriodIncreaseDecrease
364000
srne Deferred Rent And Other Period Increase Decrease
DeferredRentAndOtherPeriodIncreaseDecrease
-1258000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-209684000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-118667000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
124113000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6662000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3840000
srne Payments Related To License Agreements
PaymentsRelatedToLicenseAgreements
0
srne Payments Related To License Agreements
PaymentsRelatedToLicenseAgreements
-22325000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
82052000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28509000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
35053000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
7815000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13255000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
97810000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
72711000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
132819000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
110475000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
185815000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-17157000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
38639000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
428000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
768000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56464000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
80769000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
39735000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
120176000
us-gaap Interest Paid Net
InterestPaidNet
86000
us-gaap Interest Paid Net
InterestPaidNet
3148000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1200000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
srne Changes To Noncontrolling Interests From Increased Ownership
ChangesToNoncontrollingInterestsFromIncreasedOwnership
23963000
srne Changes To Noncontrolling Interests From Increased Ownership
ChangesToNoncontrollingInterestsFromIncreasedOwnership
0
srne Acea Acquisition Consideration Paid In Equity
ACEAAcquisitionConsiderationPaidInEquity
42168000
srne Acea Acquisition Consideration Paid In Equity
ACEAAcquisitionConsiderationPaidInEquity
0
srne Other Acquisitions License Agreements And Investments Paid In Equity
OtherAcquisitionsLicenseAgreementsAndInvestmentsPaidInEquity
13689000
srne Noncash Or Part Noncash Short Term Debt
NoncashOrPartNoncashShortTermDebt
7304000
srne Noncash Or Part Noncash Short Term Debt
NoncashOrPartNoncashShortTermDebt
0
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39735000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75176000
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
0
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
45000000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39735000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
120176000
CY2021Q3 us-gaap Goodwill
Goodwill
52900000
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
9300000
CY2020Q4 us-gaap Goodwill
Goodwill
43600000
CY2021Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
278700000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To prepare consolidated financial statements in conformity with accounting principles generally accepted in the U.S. (“U.S. GAAP”), management must make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</span></p>
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1800000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
100000
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
339440000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18470000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
320970000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
89040000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15365000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
73675000
CY2021Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1000000.0
CY2020Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1000000.0
us-gaap Adjustment For Amortization
AdjustmentForAmortization
3100000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
3000000.0
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1035000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4140000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4048000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3870000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3845000
CY2021Q3 srne Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
25372000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
42310000
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.122
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
10534000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
10520000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
34734000
CY2021Q3 srne Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
115831000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
184541000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
92967000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
91574000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2567000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10355000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
18762920
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
6707485
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.34
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1193915
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.33
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
869676
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.91
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
23406814
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.24
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
47535000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
3829618
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.68
srne Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriod
132540
srne Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedWeightedAverageGrantDateFairValue
13.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
209208
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
9.96
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3487870
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
9.50
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
3208000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
2531000
us-gaap Operating Lease Payments
OperatingLeasePayments
8081000
us-gaap Operating Lease Payments
OperatingLeasePayments
7354000
CY2021Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
39967000
CY2020Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1083000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
40141000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1878000
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
3725000
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
2580000
us-gaap Operating Lease Expense
OperatingLeaseExpense
8623000
us-gaap Operating Lease Expense
OperatingLeaseExpense
7550000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P15Y6M
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y7M6D
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P15Y6M
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y7M6D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.128
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.122
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.128
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-500000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2100000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.002
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.009
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.003
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.001
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.002
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-119803000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-84023000
us-gaap Net Income Loss
NetIncomeLoss
-283908000
us-gaap Net Income Loss
NetIncomeLoss
-226959000
CY2021Q3 us-gaap Undistributed Earnings Loss Available To Common Shareholders Diluted
UndistributedEarningsLossAvailableToCommonShareholdersDiluted
0
CY2020Q3 us-gaap Undistributed Earnings Loss Available To Common Shareholders Diluted
UndistributedEarningsLossAvailableToCommonShareholdersDiluted
-1868000
us-gaap Undistributed Earnings Loss Available To Common Shareholders Diluted
UndistributedEarningsLossAvailableToCommonShareholdersDiluted
0
us-gaap Undistributed Earnings Loss Available To Common Shareholders Diluted
UndistributedEarningsLossAvailableToCommonShareholdersDiluted
-8524000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-119803000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-85891000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-283908000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-235483000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
299276000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
251211000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
290029000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
217050000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0
CY2020Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
6459000
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
6459000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
299276000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
257670000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
290029000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
223509000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.98
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.05
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.05
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12062000
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11753000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
113449000
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
94857000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-101387000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-83104000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39735000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75176000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39828000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
28481000
us-gaap Costs And Expenses
CostsAndExpenses
326670000
us-gaap Costs And Expenses
CostsAndExpenses
202476000
us-gaap Operating Income Loss
OperatingIncomeLoss
-286842000
us-gaap Operating Income Loss
OperatingIncomeLoss
-173995000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39735000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75176000

Files In Submission

Name View Source Status
0000950170-21-003247-index-headers.html Edgar Link pending
0000950170-21-003247-index.html Edgar Link pending
0000950170-21-003247.txt Edgar Link pending
0000950170-21-003247-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img119715598_0.jpg Edgar Link pending
img119715598_1.jpg Edgar Link pending
img119715598_2.jpg Edgar Link pending
img119715598_3.jpg Edgar Link pending
img119715598_4.jpg Edgar Link pending
img119715598_5.jpg Edgar Link pending
img119715598_6.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
srne-20210930.htm Edgar Link pending
srne-20210930.xsd Edgar Link pending
srne-20210930_cal.xml Edgar Link unprocessable
srne-20210930_def.xml Edgar Link unprocessable
srne-20210930_htm.xml Edgar Link completed
srne-20210930_lab.xml Edgar Link unprocessable
srne-20210930_pre.xml Edgar Link unprocessable
srne-ex10_1.htm Edgar Link pending
srne-ex10_2.htm Edgar Link pending
srne-ex10_3.htm Edgar Link pending
srne-ex10_4.htm Edgar Link pending
srne-ex10_5.htm Edgar Link pending
srne-ex31_1.htm Edgar Link pending
srne-ex31_2.htm Edgar Link pending
srne-ex32_1.htm Edgar Link pending